IL183973A0 - Spm 927 for add -on therapy of schizophrenia - Google Patents

Spm 927 for add -on therapy of schizophrenia

Info

Publication number
IL183973A0
IL183973A0 IL183973A IL18397307A IL183973A0 IL 183973 A0 IL183973 A0 IL 183973A0 IL 183973 A IL183973 A IL 183973A IL 18397307 A IL18397307 A IL 18397307A IL 183973 A0 IL183973 A0 IL 183973A0
Authority
IL
Israel
Prior art keywords
spm
schizophrenia
therapy
add
Prior art date
Application number
IL183973A
Other languages
English (en)
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP05001843A external-priority patent/EP1688137A1/fr
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Publication of IL183973A0 publication Critical patent/IL183973A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
IL183973A 2005-01-28 2007-06-14 Spm 927 for add -on therapy of schizophrenia IL183973A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64741005P 2005-01-28 2005-01-28
EP05001843A EP1688137A1 (fr) 2005-01-28 2005-01-28 SPM 927 pour la thérapie adjuvante de la schizophrenie
PCT/EP2006/000722 WO2006079547A2 (fr) 2005-01-28 2006-01-27 Lacosamide pour traitement d'appoint

Publications (1)

Publication Number Publication Date
IL183973A0 true IL183973A0 (en) 2008-12-29

Family

ID=36636204

Family Applications (1)

Application Number Title Priority Date Filing Date
IL183973A IL183973A0 (en) 2005-01-28 2007-06-14 Spm 927 for add -on therapy of schizophrenia

Country Status (12)

Country Link
EP (1) EP1841417A2 (fr)
JP (1) JP2008528532A (fr)
KR (1) KR20070096058A (fr)
AR (1) AR057643A1 (fr)
AU (1) AU2006208630B2 (fr)
BR (1) BRPI0607043A2 (fr)
CA (1) CA2595330A1 (fr)
EA (1) EA015566B1 (fr)
IL (1) IL183973A0 (fr)
MX (1) MX2007009070A (fr)
NO (1) NO20074361L (fr)
WO (1) WO2006079547A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1873527A1 (fr) 2006-06-30 2008-01-02 Schwarz Pharma Ag Procédé d'identification des modulateurs CRMP
EP1920780A1 (fr) * 2006-10-12 2008-05-14 Schwarz Pharma Ag Composés peptidiques pour le traitement des maladies liées à l'hyperexcitabilité
EA027836B1 (ru) 2006-06-15 2017-09-29 ЮСиБи ФАРМА ГМБХ Фармацевтическая комбинация для профилактики, облегчения и/или лечения приступов эпилепсии и ее применение
CN101466390B (zh) * 2006-06-15 2014-03-12 优时比制药有限公司 用于治疗难治性癫痫持续状态的肽类化合物
EP2214657A1 (fr) 2007-10-23 2010-08-11 UCB Pharma GmbH Composés pour le traitement de conditions de démyélinisation
US20100151021A1 (en) * 2008-12-16 2010-06-17 Venkatesh Gopi M Compositions Comprising Melperone
EA029180B1 (ru) 2010-12-02 2018-02-28 Юсб Фарма Гмбх Лекарственная форма лакозамида для приема один раз в сутки
EP2468261A1 (fr) 2010-12-02 2012-06-27 UCB Pharma GmbH Formulation de lacosamide
PL3338768T3 (pl) 2016-12-20 2020-05-18 Lts Lohmann Therapie-Systeme Ag Transdermalny system terapeutyczny zawierający asenapinę
CA3047354A1 (fr) 2016-12-20 2018-06-28 Lts Lohmann Therapie-Systeme Ag Systeme therapeutique transdermique contenant de l'asenapine et un polysiloxane ou un polyisobutylene
CA3067938A1 (fr) 2017-06-26 2019-01-03 Lts Lohmann Therapie-Systeme Ag Systeme therapeutique transdermique contenant de l'asenapine et un polymere hybride acrylique de type silicone
JP7268026B2 (ja) 2017-12-05 2023-05-02 サノビオン ファーマシューティカルズ インク 非ラセミ混合物およびその使用
WO2019113084A1 (fr) 2017-12-05 2019-06-13 Sunovion Pharmaceuticals Inc. Formes cristallines et leurs procédés de production
CA3101420A1 (fr) 2018-06-20 2019-12-26 Lts Lohmann Therapie-Systeme Ag Systeme therapeutique transdermique contenant de l'asenapine
BR112021024380A2 (pt) 2019-06-04 2022-04-19 Sunovion Pharmaceuticals Inc Formulações de liberação modificadas e usos das mesmas
US11278634B1 (en) 2021-02-12 2022-03-22 Extrovis Ag Stable parenteral composition of lacosamide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378729A (en) * 1985-02-15 1995-01-03 Research Corporation Technologies, Inc. Amino acid derivative anticonvulsant
US5773475A (en) * 1997-03-17 1998-06-30 Research Corporation Technologies, Inc. Anticonvulsant enantiomeric amino acid derivatives
PT1243262E (pt) 2001-03-20 2006-10-31 Sanol Arznei Schwarz Gmbh Nova utilizacao de uma classe de compostos peptideos para o tratamento da dor inflamatoria nao neuropatica
PT1243263E (pt) 2001-03-21 2003-03-31 Sanol Arznei Schwarz Gmbh Nova utilizacao de uma classe peptidica de composto para o tratamento de alodinia ou de outros tipos diferentes de dor cronica ou fantasma

Also Published As

Publication number Publication date
EA200701594A1 (ru) 2008-02-28
WO2006079547A3 (fr) 2006-09-21
NO20074361L (no) 2007-10-26
MX2007009070A (es) 2007-09-12
KR20070096058A (ko) 2007-10-01
AU2006208630B2 (en) 2011-09-29
CA2595330A1 (fr) 2006-08-03
JP2008528532A (ja) 2008-07-31
WO2006079547A2 (fr) 2006-08-03
EP1841417A2 (fr) 2007-10-10
BRPI0607043A2 (pt) 2009-08-04
AU2006208630A1 (en) 2006-08-03
AR057643A1 (es) 2007-12-12
EA015566B1 (ru) 2011-10-31

Similar Documents

Publication Publication Date Title
IL183973A0 (en) Spm 927 for add -on therapy of schizophrenia
HK1199874A1 (en) Spiro-oxindole compounds and their uses as therapeutic agents
IL186615A0 (en) Spiroheterocylic compounds and their uses as therapeutic agents
EP1758854A4 (fr) Composes pyrrolidin-3-yle utiles en tant qu'inhibiteurs de la beta-secretase pour le traitement de la maladie d'alzheimer
EP1940373B8 (fr) 1-fluoro-1-deoxy-scyllo-inositol destine au traitement de la maladie d'alzheimer
IL190390A0 (en) Modified 4'-nucleosides as antiviral agents
EP2063889A4 (fr) Inhibiteurs de la spiropipéridine bêta-sécrétase pour le traitement de la maladie d'alzheimer
EP1807396A4 (fr) Composes de 2-aminopyridine utiles comme inhibiteurs de la beta-secretase pour le traitement de la maladie d'alzheimer
EP1809601A4 (fr) Composes destines a la maladie d'alzheimer
ZA200803440B (en) Compounds for the treatment of metabolic disorders
IL194789A0 (en) Terphenyl derivatives for treatment of alzheimer's disease
EP1951709A4 (fr) Composes d imidazolidinone utiles en tant qu inhibiteurs de la beta-secretase lors du traitement de la maladie d alzheimer
IL180513A0 (en) Process for synthesis of 4-4'-diamino-diphenyl-sulfone
IL198089A0 (en) An alzheimer's disease progression inhibitor containing heterocyclic compound having specific structure
ZA200708033B (en) Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia
EP1955698A4 (fr) Agent preventif/therapeutique pour la demence d alzheimer
HK1097831A1 (en) Benzopyran compounds useful for the treatment of arrhytmia
GB0400802D0 (en) Compounds for the treatment of disease
ZA200804266B (en) Therapeutic uses of steroidal compounds
EP1863510A4 (fr) Méthodes de traitement de la maladie de parkinson
ZA200606780B (en) Compounds for the treatment of diseases
EP1598355A4 (fr) Agent therapeutique pour la schizophrenie
ZAA200501616S (en) " an article of bedlinen "
PL373686A1 (en) Method for manufacture of 4'-hydroxyflavone
GB0425064D0 (en) Compounds useful for the treatment of diseases